[Left ventricular geometric patterns and cardiac function in patients with chronic renal failure undergoing

Maria Teresa Manes1, Manlio Gagliardi, Gianfranco Misuraca

  • 1Unità Operativa di Cardiologia, Dialisi e Trapianti-Azienda Ospedaliera di Cosenza, Italy. geniseferdinando@libero.it

Insights

Left ventricular dysfunction and geometric alterations are common in hemodialysis patients. Diastolic dysfunction often accompanies hypertrophy, while midwall shortening better detects systolic issues than endocardial measures.

Area of Science:

  • Cardiology
  • Nephrology
  • Echocardiography

Background:

  • Hemodialysis patients frequently exhibit cardiac abnormalities.
  • Left ventricular geometric alterations and dysfunction are prevalent.
  • Cardiac troponin is a marker of myocardial damage.

Purpose of the Study:

  • To estimate the prevalence of left ventricular geometric alterations and systolic/diastolic dysfunction in hemodialysis patients.
  • To investigate the relationship between these cardiac changes and cardiac troponin levels.
  • To assess the diagnostic value of midwall myocardial shortening compared to endocardial indices.

Main Methods:

  • Echocardiography was used to assess left ventricular mass, geometry, and diastolic function (IVRT, DTE, E/A ratio).
  • Cardiac troponin levels were measured using electro-chemiluminescence immunoassay.
  • Statistical analysis included t-tests and correlation analyses (Pearson, Spearman).

Main Results:

  • Eccentric hypertrophy (55%) was the most common geometric pattern.
  • Diastolic dysfunction was observed in 87% of patients.
  • Midwall myocardial shortening detected systolic dysfunction in 51% of patients, significantly higher than endocardial indices (9%).
  • Cardiac troponin correlated positively with age, left ventricular mass, and wall thickness.
  • Diastolic dysfunction was associated with more frequent hypotensive episodes during dialysis.

Conclusions:

  • Left ventricular geometry and function are frequently impaired in hemodialysis patients.
  • Diastolic dysfunction is linked to left ventricular hypertrophy but can be an early sign of myocardial damage.
  • Midwall myocardial shortening is a more sensitive indicator of left ventricular dysfunction than traditional endocardial systolic indexes.
Abstract

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of fluid...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...